Rivaroxaban

Rivaroxaban is an anticoagulant used to lower the risk of stroke in people with Afib. It works by reducing the blood’s ability to form clots. Recording your use and any side effects may help you monitor how well it fits into your care plan.

Share your experience

Your data

This graph shows how your Quality of Life (QoL) has been affected by this treatment in the past 30 days.

Community insights

Average duration of this treatment

All day

Gender of members that
reported this trigger

100.0%

0.0%

The age of our members that
reported this treatment

Members' top five risk factors

Coronary Artery Disease (CAD) 50%

Pericarditis 50%

Hypothyroidism (Underactive Thyroid) 50%

Stroke or Transient Ischemic Attack (TIA) 50%

Dementia (Including Alzheimer’s and Vascular Dementia) 50%

Effect of this treatment
on quality of life

Number of members who reported this treatment

What type of Afib members who reported this treatment have

Paroxysmal
Persistent
Long-standing persistent
Permanent

Other treatments

The percentage of reporters who reported this specific treatment

Flecainide 55.6%

Metoprolol 27.8%

Edoxaban 22.2%

Electrical Cardioversion 22.2%

Catheter Ablation 16.7%

Amiodarone 5.6%

Apixaban 5.6%

Bisoprolol 5.6%

Cryoballoon Ablation 5.6%

Dabigatran 5.6%

Diltiazem 5.6%

Radiofrequency Ablation 5.6%